Shell's Australian Shelf Sale Slips to 2027 as Santander Turns Cautious on the Stock

Shell has agreed to offload its 16.67% non-operated interest in Australia's North-West Shelf project to subsidiaries of XRG, with a base consideration of US$1.45 billion subject to customary adjustments. The deal, announced on 3 November, also carries a contingent payment tied to milestones. But the cash won't land soon: Shell expects completion in 2027, pending regulatory approvals among other conditions.

That timeline matters for anyone weighing the sale in their valuation. Signing the agreement is one thing; closing it is another. Investors who have already baked the proceeds into their models should give appropriate weight to the outstanding conditions — and treat the base consideration as the more meaningful figure, with the contingent component left tied to milestone delivery rather than booked as money in the bank.

A Cautious Analyst Voice Enters the Frame

Santander downgraded Shell to "Neutral" from "Outperform" today, trimming its price target to 4,100 pence from 4,150 pence. The shift to a neutral recommendation is the headline; the target cut itself is modest. The stock slipped 1.0% to €43.52 on the day, accompanying the more guarded assessment even as the company presses on with its share purchases.

Those buybacks are running in earnest. Shell disclosed today that it repurchased 1,969,411 of its own shares for cancellation yesterday, part of the US$5 billion programme announced roughly two weeks ago. The scheme runs through 29 January 2027. BNP Paribas handles the on-exchange leg and Natixis the off-exchange portion, with both institutions making their trading decisions independently of Shell. The purchases spanned six trading venues and included transactions in both pounds and euros.

Should investors sell immediately? Or is it worth buying Shell?

Cancellation is the stated purpose of the transactions, and the latest disclosure simply marks another step in executing the programme. Alongside it sits the interim dividend of US$0.3906 per share — the distribution backdrop against which investors can assess the potential sale proceeds.

Earnings Momentum as a Counterweight

The case for optimism rests on the pairing of the agreed disposal with a sharply higher adjusted result. Shell reported third-quarter 2026 adjusted earnings of $10.81 billion, up from $5.43 billion in the same period a year earlier. Should the sale close as expected, a transaction-driven cash inflow would sit on top of that operating base — an added positive, provided the closing conditions are met and the adjustments preserve the economic substance of the base consideration.

Sustaining that positive read, however, requires Shell to confirm the strong earnings base going forward. The year-on-year comparison supports the recent trajectory, but the sale scenario still demands its own proof of delivery.

Australia's Gas Rules Loom Over Returns

Separately, Accela Research has flagged Shell's exposure through QCLNG and Arrow as Australia weighs proposed gas reservation measures. The rules could improve domestic supply and affordability, but the impact on Shell depends on domestic delivery obligations, contract protections and the need to purchase additional gas. Shell has criticised the draft as a "sledgehammer for a nut." Accela stresses that new gas investments must still earn robust returns even under lower domestic prices and tighter regulation.

Whether the Australian gas business can generate attractive returns will hinge on the final rules for that market, where possible domestic supply mandates and the protection of existing contracts take centre stage.

Shell at a turning point? This analysis reveals what investors need to know now.

The Closing Is the Real Test

The serious counterargument is one of timing and regulatory risk. If approvals drag on or other conditions go unmet, the expected inflow shifts, and any valuation that already counts the sale in full would be left exposed. The next concrete landmark is completion, expected in 2027.

Until then, investors face a choice: give weight to the agreed cash inflow now, or tie any fuller recognition to visible progress on closing. A durable bullish case needs the earnings trajectory and the execution to line up — and Santander's neutral stance has set a more cautious valuation frame in the meantime.

Ad

Shell Stock: New Analysis - 10 November

Fresh Shell information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Shell analysis...